Ultrasound hepatic elastography: A non-invasive indicator of insulin resistance in the pediatric population: A
Reem M Elbeltagi1, Nermin K Saeed2,3, Adel S Bediwy4,5
1Department of Medicine, Royal College of Surgeons in Ireland - Medical University of Bahrain, Busaiteen 15503, Muharraq, Bahrain.
Insights
Ultrasound elastography shows a moderate link to insulin resistance in children with fatty liver disease. This non-invasive method can help assess metabolic dysfunction and track disease progression in pediatric patients.
Area of Science:
- Pediatric Gastroenterology
- Hepatology
- Metabolic Disorders
Background:
- Insulin resistance (IR) is central to metabolic dysfunction-associated steatotic liver disease (MASLD) pathogenesis.
- Non-invasive imaging is growing in pediatric use, but its reflection of IR via hepatic elastography is unclear.
Purpose of the Study:
- To assess the association between ultrasound-based hepatic elastography parameters and clinical IR indices in children.
- To determine if elastography can serve as a non-invasive marker for metabolic dysfunction in pediatric MASLD.
Main Methods:
- Systematic literature search of PubMed, Scopus, and Web of Science.
- Meta-analysis of 16 studies (2,032 children) correlating elastography (CAP/LSM) with IR indices.
- Subgroup and sensitivity analyses by IR index, cohort, and modality.
Main Results:
- Moderate positive association (r=0.44) between hepatic elastography and IR indices.
- Strongest correlations with adipose tissue IR (r=0.65) and metabolic score for IR (r=0.49).
- CAP linked to early steatosis; LSM associated with advanced fibrosis and systemic IR.
Conclusions:
- Hepatic elastography is a reliable non-invasive surrogate for systemic metabolic dysfunction in pediatric MASLD.
- CAP indicates early fat accumulation; LSM reflects fibrosis and systemic IR progression.
- Elastography shows promise for IR severity assessment, risk stratification, and monitoring in children.
Background:
Insulin resistance (IR) plays a pivotal role in the pathogenesis of metabolic dysfunction-associated steatotic liver disease. While non-invasive imaging methods are increasingly used in pediatrics, the extent to which hepatic elastography reflects IR in children remains unclear.
Aim:
To evaluate the association between ultrasound-based hepatic elastography parameters and clinical indices of IR in the pediatric population.
Methods:
A systematic search of PubMed, Scopus, and Web of Science databases was conducted through October 2025. Studies assessing correlations between elastography parameters - controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) - and IR indices were included. Data were pooled using random-effects meta-analysis with correlation coefficients (r) as the primary effect size. Subgroup and sensitivity analyses examined differences by IR index, cohort characteristics, and elastography modality.
Results:
Sixteen studies, encompassing 2,032 children and adolescents, were included. The pooled correlation between hepatic elastography (CAP/LSM) and IR indices was r = 0.44 (95% confidence interval: 0.38-0.50; I 2 = 72%), indicating a moderate positive association. The strongest correlations were observed for adipose tissue IR (r = 0.65) and the metabolic score for IR (r = 0.49), surpassing simpler indices such as homeostatic model assessment of IR. CAP correlated moderately with early steatosis (r = 0.30-0.40), whereas LSM showed stronger associations with advanced fibrosis and systemic IR (r = 0.50-0.65). Heterogeneity was mainly attributed to differences in disease severity and measurement methods.
Conclusion:
Ultrasound-based hepatic elastography provides a reliable, non-invasive surrogate for systemic metabolic dysfunction in pediatric metabolic dysfunction-associated steatotic liver disease. CAP reflects early, reversible hepatic fat accumulation, while LSM reflects more advanced fibrosis and systemic IR, and identifies fibrotic progression driven by chronic IR. The strongest associations with adipose tissue-IR and metabolic score-IR highlight the systemic, multisite nature of pediatric IR. Elastography thus holds promise as an integrated biomarker for IR severity, early risk stratification, and therapeutic monitoring in children and adolescents with metabolic risk factors.
Related Concept Videos
01:25Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
01:20Ultrasound I: Abdominal Ultrasonography
Abdominal ultrasonography, commonly known as abdominal ultrasound, is a vital, non-invasive medical imaging technique widely used in healthcare.
Procedure:
This diagnostic tool allows the clinician to visually inspect internal structures within the abdomen, including vital organs such as the liver, gallbladder, pancreas, kidneys, and spleen.
The abdominal ultrasound process begins with applying a special gel to the patient's skin over the abdomen. This gel enhances the...
01:24Imaging Studies II: Ultrasonography